Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
J Heart Valve Dis ; 16(3): 235-9, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17578041

RESUMO

BACKGROUND AND AIM OF THE STUDY: The study aim was to assess the surgical options and advantages of beating-heart aortic valve replacement (AVR) in patients with patent coronary artery bypasses. METHODS: In this prospective study, conducted between January and August 2006, four consecutive patients (mean age 77.5 +/- 6.6 years) each with patent coronary artery bypasses, underwent beating-heart AVR using two specific methods of myocardial perfusion based on the origin and status of the grafts, as assessed by preoperative angiography. Pre-operatively, all patients were in NYHA functional class III, and each received an aortic valve bioprosthesis. RESULTS: There were no hospital deaths. The mean duration of ICU stay was 3.2 +/- 1.3 days. One patient presented with transitory atrial fibrillation. At discharge, echocardiography confirmed normally functioning bioprostheses, with no significant transprosthetic gradient. CONCLUSION: Beating-heart AVR with patent coronary artery bypasses using continuous myocardial perfusion is a reliable, simple and effective technique to reduce the risks of graft and myocardial injuries, and to achieve optimal preservation of the hypertrophic myocardium with coronary artery disease.


Assuntos
Valva Aórtica/transplante , Bioprótese , Implante de Prótese de Valva Cardíaca/métodos , Próteses Valvulares Cardíacas , Idoso , Idoso de 80 Anos ou mais , Estenose da Valva Aórtica/cirurgia , Ponte de Artéria Coronária , Circulação Coronária , Humanos , Unidades de Terapia Intensiva , Tempo de Internação , Masculino , Reperfusão Miocárdica/métodos , Estudos Prospectivos , Resultado do Tratamento , Grau de Desobstrução Vascular
3.
Ann Thorac Surg ; 76(2): 617-9, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12902121

RESUMO

Heparin-induced thrombocytopenia and thrombosis syndrome (type II) is associated with thromboembolic complications and a mortality rate up to 30%. We describe a patient who developed intracardiac and aortic Dacron prosthesis heparin-induced thrombosis after aortic root conservative surgery. Successive transoesophageal echocardiographies demonstrated a progressive regression of intracardiac thrombosis with oral anticoagulation by warfarin and antiplatelet therapy combining aspirin and clopidogrel.


Assuntos
Anticoagulantes/administração & dosagem , Prótese Vascular , Cardiopatias/tratamento farmacológico , Heparina de Baixo Peso Molecular/efeitos adversos , Trombocitopenia/induzido quimicamente , Trombose/induzido quimicamente , Trombose/tratamento farmacológico , Idoso , Aneurisma da Aorta Torácica/diagnóstico por imagem , Aneurisma da Aorta Torácica/cirurgia , Aspirina/administração & dosagem , Clopidogrel , Quimioterapia Combinada , Ecocardiografia Transesofagiana , Seguimentos , Cardiopatias/induzido quimicamente , Heparina de Baixo Peso Molecular/uso terapêutico , Humanos , Medição de Risco , Índice de Gravidade de Doença , Trombocitopenia/tratamento farmacológico , Ticlopidina/administração & dosagem , Ticlopidina/análogos & derivados , Resultado do Tratamento , Varfarina/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...